Dextrothyroxine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dextrothyroxine (trade name Choloxin) saw research as an cholesterol-lowering drug but was pulled due to cardiac side-effects. It also increases hepatic lipase which in turn improves utilization of triglycerides, improving apolipoprotein E cholesterol particles.

• Levothyroxine

Template:Lipid modifying agents